Related Experiment Video

Updated: Aug 9, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
09:32

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development

Published on: June 15, 2017

Disruption of the 14-3-3 binding site within the B-Raf kinase domain uncouples catalytic activity from PC12 cell

M C MacNicol1, A J Muslin, A M MacNicol

  • 1Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA.

The Journal of Biological Chemistry
|February 8, 2000
PubMed

Insights

14-3-3 proteins bind to B-Raf, a key cell signaling kinase. Disrupting this binding impairs B-Raf

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Biochemistry

Background:

  • 14-3-3 proteins are known to interact with Raf kinases, influencing their activity.
  • The precise mechanisms by which 14-3-3 binding modulates Raf kinase function remain unclear.

Purpose of the Study:

  • To investigate the role of 14-3-3 binding to the B-Raf catalytic domain in regulating B-Raf biological activity.
  • To determine if 14-3-3 interaction is necessary for B-Raf's kinase activity or its downstream signaling.

Main Methods:

  • Site-directed mutagenesis to disrupt 14-3-3 binding sites on B-Raf.
  • Expression of wild-type and mutant B-Raf catalytic domains in PC12 cells.
  • Assays for PC12 cell differentiation induction.
  • In vitro kinase assays.
  • Experiments in Xenopus oocytes to assess progesterone-stimulated maturation and mitogen-activated protein kinase (MAPK) pathway activation.

Main Results:

  • Mutational disruption of 14-3-3 binding to the B-Raf catalytic domain significantly inhibited B-Raf's ability to induce PC12 cell differentiation.
  • The B-Raf catalytic domain mutant retained significant in vitro kinase activity, indicating 14-3-3 binding is not essential for catalytic function.
  • In Xenopus oocytes, the B-Raf 14-3-3 binding mutant blocked progesterone-induced maturation and MAPK activation.
  • The mutant also inhibited nerve growth factor-stimulated PC12 cell differentiation.

Conclusions:

  • 14-3-3 interaction with the B-Raf catalytic domain is crucial for coupling B-Raf's kinase activity to downstream signaling pathways.
  • This interaction is not required for the intrinsic kinase activity of B-Raf but is essential for its biological function in cell differentiation and maturation.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...